|10-05-2008, 11:30 AM||#1|
Join Date: Sep 2004
Transplantation of vascular cells derived from human embryonic stem cells to mice
J Transl Med. 2008 Sep 30;6(1):54.
Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice.
Oyamada N, Itoh H, Sone M, Yamahara K, Miyashita K, Kwijun P, Taura D, Inuzuka M, Sonoyama T, Tsujimoto H, Fukunaga Y, Tamura N, Nakao K.
ABSTRACT: Background We previously demonstrated that vascular endothelial growth factor receptor type 2 (VEGF-R2)-positive cells induced from mouse embryonic stem (ES) cells can differentiate into both endothelial cells (ECs) and mural cells (MCs) and these vascular cells construct blood vessel structures in vitro. Recently, we have also established a method for the large-scale expansion of ECs and MCs derived from human ES cells. We examined the potential of vascular cells derived from human ES cells to contribute to vascular regeneration and to provide therapeutic benefit for the ischemic brain. Methods Phosphate buffered saline, human peripheral blood mononuclear cells (hMNCs), ECs-, MCs-, or the mixture of ECs and MCs derived from human ES cells were intra-arterially transplanted into mice after transient middle cerebral artery occlusion (MCAo). Results Transplanted ECs were successfully incorporated into host capillaries and MCs were distributed in the areas surrounding endothelial tubes. The cerebral blood flow and the vascular density in the ischemic striatum on day 28 after MCAo had significantly improved in ECs-, MCs- and ECs+MCs-transplanted mice compared to that of mice injected with saline or transplanted with hMNCs. Moreover, compared to saline-injected or hMNC-transplanted mice, significant reduction of the infarct volume and of apoptosis as well as acceleration of neurological recovery were observed on day 28 after MCAo in the cell mixture-transplanted mice. Conclusions Transplantation of ECs and MCs derived from undifferentiated human ES cells have a potential to contribute to therapeutic vascular regeneration and consequently reduction of infarct area after stroke.
“As the cast of villains in SCI is vast and collaborative, so too must be the chorus of hero's that rise to meet them” Ramer et al 2005
|Thread||Thread Starter||Forum||Replies||Last Post|
|Dr. Young on Cloning & an Opposing View||James Kelly||Cure||50||11-14-2006 03:18 PM|
|A scientific rationale for studying cloned stem cells||Wise Young||Cure||11||06-14-2006 01:50 PM|
|Exciting Strides Being Made in Stem Cell Research||Leif||Cure||0||12-12-2005 07:25 PM|
|Stem cell research in the U.S. and the world during the past decade||Wise Young||Cure||0||01-18-2005 02:52 AM|
|...worth a thousand words.||James Kelly||Cure||3||06-02-2002 12:15 AM|